• Click to join the WMHT e-news mailing list
  • Click to make a sustaining contribution to WMHT
  • Click to contribute to WMHT
  • In Partnership With:
  • PBS
  • NPR

Next on Health Link: High Blood Pressure

Got high blood pressure?  Not so fast.  New guidelines could significantly change the way doctors think about hypertension and whether or not to prescribe medications.  Hypertension is known as the silent killer because it has no warning signs or symptoms. Uncontrolled it can lead to heart disease, stroke, and kidney disease.  On HEALTH LINK we’ll examine the prevention, diagnosis and treatment of hypertension.  Find out what the new guidelines mean for you.

Watch:
Thursday, September 25, 2014 at 7:30pm &
Sunday, September 28, 2014 at 10am

GUESTS

Arif Asif, MD
Dr. Arif Asif is chief of nephrology and hypertension at Albany Medical Center.

Roberta Flesh, MD
Dr. Roberta Flesh practices internal and geriatric medicine at Albany Stratton VA Medical Center.

Dr. Michael J. Martinelli, MD, FACC, FSCAI
Dr. Michael Martinelli is Chief of Cardiology at St. Peter’s Hospital. 

RELATED RESOURCES

American Heart Association

Centers for Disease Control and Prevention

National Kidney Foundation, Inc.

National Institutes of Health  

        - High Blood Pressure

        - High Blood Pressure and Kidney Disease

National Stroke Association

Northeast Kidney Foundation, Inc.

---

Disclaimer: This information is not intended to be medical advice. By clicking the links above, you will be leaving WMHT.org. WMHT Educational Telecommunications has *not* made any determination about the quality of the information within these links, nor does it endorse any information, service, product or company included within the links above. 

Stock Photos provided by Shutterstock.

Underwriting Provided By:

St. Peter's Health Partners

Marra's Health Mart

Rubin Dialysis Center

NPR Health News

Next Avenue News

Is Being Bald a Clue to Cancer? Is Being Bald a Clue to Cancer?
Male pattern baldness in midlife may illuminate prostate risks.